Almeda Ventures

Almeda Ventures, established in 2020 and based in Tel Aviv, Israel, is a venture capital firm specializing in HealthTech. The firm focuses on investing in medical devices, digital health, and bio-convergence sectors on a global scale. By leveraging its team's deep expertise and extensive network that includes investors, strategic partners, and medical centers worldwide, Almeda Ventures aims to support the growth and success of its portfolio companies.

Amir Blatt

Founding Partner and CIO

Shany Steinmetz

Associate

Tzahi Sultan

Founding Partner

9 past transactions

Augmedics

Series D in 2023
Augmedics Ltd. is a company that specializes in augmented reality surgical guidance systems, aiming to enhance the safety and effectiveness of surgical procedures. Founded in 2014 and headquartered in Yoqneam Ilit, Israel, with an additional office in Chicago, Illinois, the company has developed the xvision-spine (XVS) system. This innovative system features a head-mounted display that allows surgeons to visualize a patient's anatomy through skin and tissue, providing real-time insights into the position of surgical tools and illuminating the surgical area. By integrating advanced technologies, Augmedics seeks to transform surgical treatment and improve patient outcomes during complex operations.

Sensi.AI

Series A in 2021
Sensi.AI specializes in audio technology that monitors and detects potential abnormalities in the care of seniors, particularly those with mental impairments. By utilizing advanced voice analytics, Sensi.AI provides home care businesses with a comprehensive understanding of a senior's physical, emotional, and cognitive needs, thereby enhancing care efficiency and growth. The technology operates discreetly, employing audio recorders to monitor environments, including private spaces, while ensuring the privacy of patients is maintained. Additionally, it offers conditional alerts that allow family members to oversee the quality of care provided by caregivers, enhancing trust and transparency in the care process.

FlexDex

Venture Round in 2021
FlexDex Inc. is a company focused on developing minimally invasive surgery (MIS) devices. Its innovative platform technology allows for the translation of a surgeon's hand, wrist, and arm movements from outside the patient into precise movements of an end-effector inside the body, thereby enhancing the functionality of MIS instruments and endoscopes. The company collaborates with distributors to serve healthcare professionals both in the United States and internationally. Founded in 2010 and based in Brighton, Michigan, FlexDex aims to improve surgical outcomes through its advanced medical device technology.

TailorMed

Venture Round in 2021
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.

Augmedics

Series C in 2021
Augmedics Ltd. is a company that specializes in augmented reality surgical guidance systems, aiming to enhance the safety and effectiveness of surgical procedures. Founded in 2014 and headquartered in Yoqneam Ilit, Israel, with an additional office in Chicago, Illinois, the company has developed the xvision-spine (XVS) system. This innovative system features a head-mounted display that allows surgeons to visualize a patient's anatomy through skin and tissue, providing real-time insights into the position of surgical tools and illuminating the surgical area. By integrating advanced technologies, Augmedics seeks to transform surgical treatment and improve patient outcomes during complex operations.

Lumen

Venture Round in 2020
Lumen is a company that has developed a portable device and accompanying app designed to measure metabolism through a simple breath test. This innovative technology provides users with daily personalized nutrition guidance based on their metabolic data, helping them achieve various health and fitness goals such as weight loss, performance optimization, and improved metabolic health. The device functions as a real-time breathalyzer that allows individuals to understand their metabolic trends and make informed decisions about their dietary habits. With a focus on enhancing personal health through metabolic insights, Lumen aims to change how people approach nutrition and body management. The team comprises scientists, researchers, engineers, and designers dedicated to making metabolism more accessible and understandable for everyone.

Nurami

Venture Round in 2020
Nurami Medical focuses on creating advanced surgical scaffolds aimed at enhancing the repair and regeneration of soft tissues following internal surgeries. Utilizing electrospinning technology, the company develops biomaterials and nanofiber-based matrices that improve patient outcomes in various surgical procedures. These matrices feature a porous scaffold that promotes tissue regeneration and incorporate a novel temperature-sensitive sealant designed to prevent pathogen entry and cerebrospinal fluid leaks. This innovative approach addresses critical needs in surgical treatment, providing surgeons with effective solutions for their patients.

TailorMed

Venture Round in 2020
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.

BioProtect

Venture Round in 2020
BioProtect Ltd. is an international medical device startup focused on developing and commercializing biodegradable balloon spacers designed to protect normal tissue during cancer radiation therapy. The company's flagship product, the ProSpace balloon spacer, has demonstrated superior efficacy and safety in safeguarding the rectum during radiation treatment for prostate cancer. This innovative technology significantly reduces the risk of serious and chronic side effects associated with radiation, while enhancing tumor control. Founded in 2004 and headquartered in Israel, BioProtect also operates subsidiaries in Germany and the United States, aiming to address unmet clinical needs in the growing radiotherapy spacers market with its platform of biodegradable implantable balloons.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.